WASHINGTON, D.C. – An op-ed authored by AdvaMed President and CEO Scott Whitaker was published today in Morning Consult on the importance of COVID-19 diagnostic testing and the role AdvaMed’s new national testing supply registry will play in helping the federal and state governments create and manage COVID-19 diagnostic testing strategies.
Behind the scenes, the medical technology industry is working around-the-clock to manufacture the critical supplies providers need to combat the coronavirus. Across the country, manufacturers are adding shifts, ramping up alternative production lines and working overtime to produce personal protective equipment (PPE), ventilators and the diagnostic tests desperately needed on the front lines.
Scott Whitaker, AdvaMed’s President & CEO, recently joined host David Westin on Bloomberg Radio’s “Balance of Power” program to provide a national audience with an update on how the medical technology industry has mobilized to combat the COVID-19 pandemic.
With the support of AdvaMed’s membership, Scott Whitaker signed the CEO Action for Diversity and Inclusion pledge, the largest CEO-driven business commitment to advance diversity and inclusion within the workplace.
The Business Roundtable (BRT) recently released a brief but powerful “Statement on the Purpose of a Corporation,” which reinforces the importance of serving all company stakeholders, even as each company serves its own corporate purpose.